Norwegian Institute for Water Research, Gaustadalléen 21, NO-0349, Oslo, Norway; Faculty of Medicine, University of Oslo, PO box 1078 Blindern, 0316, Oslo, Norway.
Norwegian Institute for Water Research, Gaustadalléen 21, NO-0349, Oslo, Norway.
Anal Chim Acta. 2016 Mar 31;914:81-90. doi: 10.1016/j.aca.2016.01.056. Epub 2016 Feb 10.
The quantification of illicit drug and pharmaceutical residues in sewage has been shown to be a valuable tool that complements existing approaches in monitoring the patterns and trends of drug use. The present work delineates the development of a novel analytical tool and dynamic workflow for the analysis of a wide range of substances in sewage-based samples. The validated method can simultaneously quantify 51 target psychoactive substances and pharmaceuticals in sewage-based samples using an off-line automated solid phase extraction (SPE-DEX) method, using Oasis HLB disks, followed by ultra-high performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry (UHPLC-QTOF) in MS(e). Quantification and matrix effect corrections were overcome with the use of 25 isotopic labeled internal standards (ILIS). Recoveries were generally greater than 60% and the limits of quantification were in the low nanogram-per-liter range (0.4-187 ng L(-1)). The emergence of new psychoactive substances (NPS) on the drug scene poses a specific analytical challenge since their market is highly dynamic with new compounds continuously entering the market. Suspect screening using high-resolution mass spectrometry (HRMS) simultaneously allowed the unequivocal identification of NPS based on a mass accuracy criteria of 5 ppm (of the molecular ion and at least two fragments) and retention time (2.5% tolerance) using the UNIFI screening platform. Applying MS(e) data against a suspect screening database of over 1000 drugs and metabolites, this method becomes a broad and reliable tool to detect and confirm NPS occurrence. This was demonstrated through the HRMS analysis of three different sewage-based sample types; influent wastewater, passive sampler extracts and pooled urine samples resulting in the concurrent quantification of known psychoactive substances and the identification of NPS and pharmaceuticals.
污水中非法药物和药物残留的定量分析已被证明是一种很有价值的工具,可补充现有的药物使用监测模式和趋势的方法。本工作描述了一种新的分析工具和动态工作流程的开发,用于分析污水基样品中的广泛物质。该验证方法可使用离线自动化固相萃取(SPE-DEX)方法,使用 Oasis HLB 圆盘,然后使用超高效液相色谱-四极杆飞行时间质谱(UHPLC-QTOF)在 MS(e)中同时定量分析 51 种目标精神活性物质和药物污水基样品。使用 25 种同位素标记内标(ILIS)进行定量和基质效应校正。回收率通常大于 60%,定量限在纳克/升低水平(0.4-187ngL(-1))。新精神活性物质(NPS)在药物领域的出现带来了特定的分析挑战,因为它们的市场具有高度动态性,新化合物不断进入市场。使用高分辨率质谱(HRMS)进行嫌疑筛查,同时允许根据分子离子和至少两个碎片的质量准确度标准(5ppm)和保留时间(2.5%的公差),使用 UNIFI 筛选平台对 NPS 进行明确识别。使用针对超过 1000 种药物和代谢物的嫌疑筛查数据库的 MS(e)数据,该方法成为一种广泛且可靠的工具,可用于检测和确认 NPS 的发生。通过对三种不同污水基样品类型(进水废水、被动采样器提取物和混合尿液样品)的 HRMS 分析,证明了这一点,结果同时定量分析了已知的精神活性物质,并鉴定了 NPS 和药物。